Mark Sheptoff Financial Planning’s Gritstone bio, Inc. Common Stock GRTS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q3
Sell
-601
Closed -$5K 438
2021
Q2
$5K Buy
601
+250
+71% +$2.31K ﹤0.01% 368
2021
Q1
$3K Buy
+351
New +$4.83K ﹤0.01% 344

Other funds holding GRTS

Mark Sheptoff Financial Planning's GRTS Position: Q3 2021 in Review

Mark Sheptoff Financial Planning sold out of Gritstone bio, Inc. Common Stock (GRTS) in Q3 2021, closing a stake of 601 shares — an estimated $5K sold.

Mark Sheptoff Financial Planning first reported a position in GRTS in Q1 2021 and held it in 2 quarters. The position peaked at $5K in Q2 2021. 92 funds tracked by Wall St. Rank hold GRTS as of Q3 2021.

  • Mark Sheptoff Financial Planning reported no remaining Gritstone bio, Inc. Common Stock position as of Q3 2021 after selling out during the quarter.
  • Mark Sheptoff Financial Planning sold 601 Gritstone bio, Inc. Common Stock shares in Q3 2021, an estimated $5K.
  • Mark Sheptoff Financial Planning first reported a position in Gritstone bio, Inc. Common Stock in Q1 2021 and held it in 2 quarters.
  • Mark Sheptoff Financial Planning's Gritstone bio, Inc. Common Stock position peaked at $5K in Q2 2021.
  • 92 funds tracked by Wall St. Rank held Gritstone bio, Inc. Common Stock as of Q3 2021.

Based on Mark Sheptoff Financial Planning's 13F filing for Q3 2021, filed 10 Nov 2021.